Year |
Citation |
Score |
2016 |
Zhao Z, Harrison ST, Schubert JW, Sanders JM, Polsky-Fisher S, Zhang NR, McLoughlin D, Gibson CR, Robinson RG, Sachs NA, Kandebo M, Yao L, Smith SM, Hutson PH, Wolkenberg SE, et al. Synthesis and optimization of N-heterocyclic pyridinones as catechol-O-methyltransferase (COMT) inhibitors. Bioorganic & Medicinal Chemistry Letters. PMID 27133481 DOI: 10.1016/J.Bmcl.2016.03.095 |
0.302 |
|
2010 |
Nicolaou KC, Gray DLF, Montagnon T, Harrison ST. ChemInform Abstract: Oxidation of Silyl Enol Ethers by Using IBX and IBX×N-Oxide Complexes: A Mild and Selective Reaction for the Synthesis of Enones. Cheminform. 33: no-no. DOI: 10.1002/chin.200231052 |
0.378 |
|
2009 |
Nicolaou KC, Harrison ST, Chen JS. Discoveries from the Abyss: The Abyssomicins and Their Total Synthesis. Synthesis. 2009: 33-42. PMID 20047014 DOI: 10.1055/S-0028-1083259 |
0.482 |
|
2009 |
Nicolaou KC, Harrison ST, Chen JS. ChemInform Abstract: Discoveries from the Abyss: The Abyssomicins and Their Total Synthesis Cheminform. 40. DOI: 10.1002/chin.200913239 |
0.385 |
|
2007 |
Nicolaou KC, Harrison ST. Total synthesis of abyssomicin C, atrop-abyssomicin C, and abyssomicin D: implications for natural origins of atrop-abyssomicin C. Journal of the American Chemical Society. 129: 429-40. PMID 17212423 DOI: 10.1021/Ja067083P |
0.457 |
|
2006 |
Nicolaou KC, Harrison ST. Total synthesis of abyssomicin C and atrop-abyssomicin C. Angewandte Chemie (International Ed. in English). 45: 3256-60. PMID 16634106 DOI: 10.1002/Anie.200601116 |
0.448 |
|
2006 |
Nicolaou KC, Denton RM, Lenzen A, Edmonds DJ, Li A, Milburn RR, Harrison ST. Stereocontrolled synthesis of model core systems of lomaiviticins A and B. Angewandte Chemie (International Ed. in English). 45: 2076-81. PMID 16496276 DOI: 10.1002/Anie.200504466 |
0.519 |
|
2006 |
Nicolaou K, Harrison S. Synthesis of Abyssomicin C Synfacts. 2006: 1092-1092. DOI: 10.1055/S-2006-949397 |
0.471 |
|
2002 |
Nicolaou KC, Gray DL, Montagnon T, Harrison ST. Oxidation of silyl enol ethers by using IBX and IBX.N-oxide complexes: a mild and selective reaction for the synthesis of enones. Angewandte Chemie (International Ed. in English). 41: 996-1000. PMID 12491292 DOI: 10.1002/1521-3773(20020315)41:6<996::Aid-Anie996>3.0.Co;2-I |
0.501 |
|
Low-probability matches (unlikely to be authored by this person) |
2011 |
Harrison ST, Mulhearn J, Wolkenberg SE, Miller PJ, O'Malley SS, Zeng Z, Williams DL, Hostetler ED, Sanabria-Bohórquez S, Gammage L, Fan H, Sur C, Culberson JC, Hargreaves RJ, Cook JJ, et al. Synthesis and Evaluation of 5-Fluoro-2-aryloxazolo[5,4-b]pyridines as β-Amyloid PET Ligands and Identification of MK-3328. Acs Medicinal Chemistry Letters. 2: 498-502. PMID 24900338 DOI: 10.1021/Ml200018N |
0.281 |
|
2020 |
Tong L, Li W, Lo MM, Gao X, Wai JM, Rudd MT, Tellers DM, Joshi A, Zeng Z, Miller P, Salinas C, Riffel K, Haley HD, Purcell M, Holahan M, ... ... Harrison ST, et al. Discovery of [11C]MK-6884: A Positron Emission Tomography (PET) Imaging Agent for the Study of M4 Muscarinic Receptor Positive Allosteric Modulators (PAMs) in Neurodegenerative Diseases. Journal of Medicinal Chemistry. PMID 32101422 DOI: 10.1021/Acs.Jmedchem.9B01406 |
0.278 |
|
2015 |
Harrison ST, Poslusney MS, Mulhearn JJ, Zhao Z, Kett NR, Schubert JW, Melamed JY, Allison TJ, Patel SB, Sanders JM, Sharma S, Smith RF, Hall DL, Robinson RG, Sachs NA, et al. Synthesis and Evaluation of Heterocyclic Catechol Mimics as Inhibitors of Catechol-O-methyltransferase (COMT). Acs Medicinal Chemistry Letters. 6: 318-23. PMID 25815153 DOI: 10.1021/Ml500502D |
0.268 |
|
2011 |
Hostetler ED, Sanabria-Bohórquez S, Fan H, Zeng Z, Gammage L, Miller P, O'Malley S, Connolly B, Mulhearn J, Harrison ST, Wolkenberg SE, Barrow JC, Williams DL, Hargreaves RJ, Sur C, et al. [18F]Fluoroazabenzoxazoles as potential amyloid plaque PET tracers: synthesis and in vivo evaluation in rhesus monkey. Nuclear Medicine and Biology. 38: 1193-203. PMID 21741254 DOI: 10.1016/J.Nucmedbio.2011.04.004 |
0.253 |
|
2012 |
Robinson RG, Smith SM, Wolkenberg SE, Kandebo M, Yao L, Gibson CR, Harrison ST, Polsky-Fisher S, Barrow JC, Manley PJ, Mulhearn JJ, Nanda KK, Schubert JW, Trotter BW, Zhao Z, et al. Characterization of non-nitrocatechol pan and isoform specific catechol-O-methyltransferase inhibitors and substrates. Acs Chemical Neuroscience. 3: 129-40. PMID 22860182 DOI: 10.1021/Cn200109W |
0.245 |
|
2019 |
Schubert JW, Harrison ST, Mulhearn J, Gomez R, Tynebor R, Jones K, Bunda J, Hanney B, Wai JM, Cox C, McCauley JA, Sanders JM, Magliaro B, O'Brien J, Pajkovic N, et al. Discovery, Optimization, and Biological Characterization of 2,3,6-Trisubstituted Pyridine-Containing M Positive Allosteric Modulators. Chemmedchem. PMID 30920765 DOI: 10.1002/Cmdc.201900088 |
0.243 |
|
2010 |
Sur C, Zeng Z, Hostetler E, Connolly BM, Miller PJ, O'Malley S, Chen T, Culberson C, Harrison S, Mulhearn J, Wolkenberg S, Barrow J, Sanabria S, Cook JJ, Hargreaves R, et al. In vitro Characterization of MK-3328: A Novel Fluorinated Positron Emission Tomography Tracer for Plaques Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.112 |
0.23 |
|
2011 |
Wolkenberg SE, Zhao Z, Mulhearn JJ, Harrison ST, Sanders JM, Cato MJ, Jovanovska A, Panigel J, Cook SP, Henze DA, Kane SA, Hartman GD, Barrow JC. High concentration electrophysiology-based fragment screen: discovery of novel acid-sensing ion channel 3 (ASIC3) inhibitors. Bioorganic & Medicinal Chemistry Letters. 21: 2646-9. PMID 21257308 DOI: 10.1016/J.Bmcl.2010.12.115 |
0.23 |
|
2010 |
Hostetler E, Sanabria-Bohórquez S, Fan H, Zeng Z, Williams D, O'Malley S, Miller P, Chen T, Culberson C, Daneker L, Harrison S, Mulhearn J, Wolkenberg S, Barrow J, Hargreaves R, et al. [F-18]MK-3328: Evaluation of a novel PET tracer for amyloid plaque in rhesus monkey Neuroimage. 52: S154. DOI: 10.1016/J.Neuroimage.2010.04.126 |
0.223 |
|
2017 |
Harrison S, Lahue B, Peng Z, Donofrio A, Chang C, Glick M. Extending 'predict first' to the design-make-test cycle in small-molecule drug discovery. Future Medicinal Chemistry. PMID 28402685 DOI: 10.4155/Fmc-2017-0025 |
0.189 |
|
2012 |
Harrison S, Xue H, Lane G, Villas-Boas S, Rasmussen S. Linear ion trap MS(n) of enzymatically synthesized 13C-labeled fructans revealing differentiating fragmentation patterns of β (1-2) and β (1-6) fructans and providing a tool for oligosaccharide identification in complex mixtures. Analytical Chemistry. 84: 1540-8. PMID 22145650 DOI: 10.1021/Ac202816Y |
0.107 |
|
1992 |
Harrison ST, Chase HA, Amor SR, Bonthrone KM, Sanders JK. Plasticization of poly(hydroxybutyrate) in vivo. International Journal of Biological Macromolecules. 14: 50-6. PMID 1596472 DOI: 10.1016/S0141-8130(05)80020-0 |
0.102 |
|
2012 |
Oyekola OO, Harrison ST, van Hille RP. Effect of culture conditions on the competitive interaction between lactate oxidizers and fermenters in a biological sulfate reduction system. Bioresource Technology. 104: 616-21. PMID 22154582 DOI: 10.1016/j.biortech.2011.11.052 |
0.096 |
|
2015 |
Kantor RS, van Zyl AW, van Hille RP, Thomas BC, Harrison ST, Banfield JF. Bioreactor microbial ecosystems for thiocyanate and cyanide degradation unraveled with genome-resolved metagenomics. Environmental Microbiology. PMID 26031303 DOI: 10.1111/1462-2920.12936 |
0.088 |
|
2010 |
Griffiths MJ, van Hille RP, Harrison ST. Selection of direct transesterification as the preferred method for assay of fatty acid content of microalgae. Lipids. 45: 1053-60. PMID 20820931 DOI: 10.1007/s11745-010-3468-2 |
0.074 |
|
2013 |
Olaofe OA, Fenner CJ, Gudiminchi RK, Smit MS, Harrison ST. The influence of microbial physiology on biocatalyst activity and efficiency in the terminal hydroxylation of n-octane using Escherichia coli expressing the alkane hydroxylase, CYP153A6. Microbial Cell Factories. 12: 8. PMID 23351575 DOI: 10.1186/1475-2859-12-8 |
0.064 |
|
1931 |
Harrison ST, Mellanby E. A note on the inhibitory effect of monoiodoacetic acid on lactic acid production by cancer tissue. The Biochemical Journal. 25: 770-2. PMID 16744639 |
0.063 |
|
1930 |
Harrison ST, Mellanby E. The inhibition of lactic acid formation in cancer and muscle. The Biochemical Journal. 24: 141-57. PMID 16744336 |
0.062 |
|
2005 |
Rozen S, Cudkowicz ME, Bogdanov M, Matson WR, Kristal BS, Beecher C, Harrison S, Vouros P, Flarakos J, Vigneau-Callahan K, Matson TD, Newhall KM, Beal MF, Brown RH, Kaddurah-Daouk R. Metabolomic analysis and signatures in motor neuron disease. Metabolomics : Official Journal of the Metabolomic Society. 1: 101-108. PMID 18820733 DOI: 10.1007/S11306-005-4810-1 |
0.061 |
|
2007 |
Icgen B, Moosa S, Harrison ST. A study of the relative dominance of selected anaerobic sulfate-reducing bacteria in a continuous bioreactor by fluorescence in situ hybridization. Microbial Ecology. 53: 43-52. PMID 16941240 DOI: 10.1007/s00248-006-9009-0 |
0.057 |
|
2012 |
Bryan CG, Davis-Belmar CS, van Wyk N, Fraser MK, Dew D, Rautenbach GF, Harrison ST. The effect of CO2 availability on the growth, iron oxidation and CO2-fixation rates of pure cultures of Leptospirillum ferriphilum and Acidithiobacillus ferrooxidans. Biotechnology and Bioengineering. 109: 1693-703. PMID 22383083 DOI: 10.1002/bit.24453 |
0.053 |
|
2007 |
Harding KG, Dennis JS, von Blottnitz H, Harrison ST. Environmental analysis of plastic production processes: comparing petroleum-based polypropylene and polyethylene with biologically-based poly-beta-hydroxybutyric acid using life cycle analysis. Journal of Biotechnology. 130: 57-66. PMID 17400318 DOI: 10.1016/J.Jbiotec.2007.02.012 |
0.052 |
|
2023 |
Foster L, Boothman C, Harrison S, Jenkinson P, Pittman JK, Lloyd JR. Identification of algal rich microbial blooms in the Sellafield Pile Fuel Storage Pond and the application of ultrasonic treatment to control the formation of blooms. Frontiers in Microbiology. 14: 1261801. PMID 37860139 DOI: 10.3389/fmicb.2023.1261801 |
0.052 |
|
2011 |
Harrison S, Fraser K, Lane G, Hughes D, Villas-Boas S, Rasmussen S. Analysis of high-molecular-weight fructan polymers in crude plant extracts by high-resolution LC-MS. Analytical and Bioanalytical Chemistry. 401: 2955-63. PMID 21927982 DOI: 10.1007/S00216-011-5374-8 |
0.047 |
|
2006 |
Balasundaram B, Harrison ST. Disruption of Brewers' yeast by hydrodynamic cavitation: Process variables and their influence on selective release. Biotechnology and Bioengineering. 94: 303-11. PMID 16570316 DOI: 10.1002/bit.20878 |
0.046 |
|
2014 |
Griffiths MJ, van Hille RP, Harrison ST. The effect of degree and timing of nitrogen limitation on lipid productivity in Chlorella vulgaris. Applied Microbiology and Biotechnology. 98: 6147-59. PMID 24824221 DOI: 10.1007/s00253-014-5757-9 |
0.045 |
|
2020 |
Marchand K, Foreman J, MacDonald S, Harrison S, Schechter MT, Oviedo-Joekes E. Building healthcare provider relationships for patient-centered care: A qualitative study of the experiences of people receiving injectable opioid agonist treatment. Substance Abuse Treatment, Prevention, and Policy. 15: 7. PMID 31959189 DOI: 10.1186/s13011-020-0253-y |
0.044 |
|
2020 |
McColeman C, Thompson J, Anvari N, Azmand SJ, Barnes J, Barrett RCA, Byliris R, Chen Y, Dolguikh K, Fischler K, Harrison S, Hayre RS, Poe R, Swanson L, Tracey T, et al. Digit eyes: Learning-related changes in information access in a computer game parallel those of oculomotor attention in laboratory studies. Attention, Perception & Psychophysics. PMID 32333371 DOI: 10.3758/s13414-020-02019-w |
0.043 |
|
2008 |
Balasundaram B, Harrison ST, Li J, Chase HA. A study of the influence of yeast cell debris on protein and alpha-glucosidase adsorption at various zones within the expanded bed using in-bed sampling. Biotechnology and Bioengineering. 99: 614-24. PMID 17680682 DOI: 10.1002/Bit.21586 |
0.043 |
|
2023 |
Dobischok S, Guh D, Marchand K, MacDonald S, Lock K, Harrison S, Lajeunesse J, Schechter MT, Oviedo-Joekes E. The Impact of Injectable Opioid Agonist Treatment (iOAT) on Involvement in Criminalized Activities: A Secondary Analysis from a Clinical Trial in Vancouver, BC. Substance Abuse and Rehabilitation. 14: 147-156. PMID 38026787 DOI: 10.2147/SAR.S438451 |
0.041 |
|
2023 |
Jaffe K, Blawatt S, Lehal E, Lock K, Easterbrook A, MacDonald S, Harrison S, Lajeunesse J, Byres D, Schechter M, Oviedo-Joekes E. "As long as that place stays open, I'll stay alive": Accessing injectable opioid agonist treatment during dual public health crises. Harm Reduction Journal. 20: 51. PMID 37060027 DOI: 10.1186/s12954-023-00779-w |
0.039 |
|
2012 |
Gudiminchi RK, Randall C, Opperman DJ, Olaofe OA, Harrison ST, Albertyn J, Smit MS. Whole-cell hydroxylation of n-octane by Escherichia coli strains expressing the CYP153A6 operon. Applied Microbiology and Biotechnology. 96: 1507-16. PMID 22410745 DOI: 10.1007/S00253-012-3984-5 |
0.038 |
|
2019 |
Marchand K, Beaumont S, Westfall J, MacDonald S, Harrison S, Marsh DC, Schechter MT, Oviedo-Joekes E. Conceptualizing patient-centered care for substance use disorder treatment: findings from a systematic scoping review. Substance Abuse Treatment, Prevention, and Policy. 14: 37. PMID 31511016 DOI: 10.1186/s13011-019-0227-0 |
0.038 |
|
2021 |
Marchand K, Palis H, Guh D, Lock K, MacDonald S, Brissette S, Marsh DC, Harrison S, Schechter MT, Oviedo-Joekes E. A multi-methods and longitudinal study of patients' perceptions in injectable opioid agonist treatment: Implications for advancing patient-centered methodologies in substance use research. Journal of Substance Abuse Treatment. 132: 108512. PMID 34098207 DOI: 10.1016/j.jsat.2021.108512 |
0.038 |
|
2023 |
Dobischok S, Carvajal JR, Turner K, Jaffe K, Lehal E, Blawatt S, Redquest C, Baltzer Turje R, McDougall P, Koch B, McDermid C, Hassan D, Harrison S, Oviedo-Joekes E. "It feels like I'm coming to a friend's house": an interpretive descriptive study of an integrated care site offering iOAT (Dr. Peter Centre). Addiction Science & Clinical Practice. 18: 73. PMID 38042844 DOI: 10.1186/s13722-023-00428-4 |
0.036 |
|
2023 |
Blawatt S, Arreola LAG, Magel T, MacDonald S, Harrison S, Schechter MT, Oviedo-Joekes E. Changes in daily dose in open-label compared to double-blind: The role of clients' expectations in injectable opioid agonist treatment. Addictive Behaviors Reports. 17: 100490. PMID 37124402 DOI: 10.1016/j.abrep.2023.100490 |
0.035 |
|
2023 |
Adams A, Blawatt S, Magel T, MacDonald S, Lajeunesse J, Harrison S, Byres D, Schechter MT, Oviedo-Joekes E. The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review. Substance Abuse Treatment, Prevention, and Policy. 18: 56. PMID 37777766 DOI: 10.1186/s13011-023-00564-9 |
0.032 |
|
1991 |
Harrison ST, Dennis JS, Chase HA. Combined chemical and mechanical processes for the disruption of bacteria. Bioseparation. 2: 95-105. PMID 1368079 |
0.032 |
|
2022 |
Dobischok S, Metcalfe R, Matzinger E, Palis H, Marchand K, Harrison S, MacDonald S, Byres D, Schechter M, Bansback N, Oviedo-Joekes E. Measuring the preferences of injectable opioid agonist treatment (iOAT) clients: Development of a person-centered scale (best-worst scaling). The International Journal On Drug Policy. 112: 103948. PMID 36586152 DOI: 10.1016/j.drugpo.2022.103948 |
0.031 |
|
2021 |
Palis H, Marchand K, Peachey GS, Westfall J, Lock K, MacDonald S, Jun J, Bojanczyk-Shibata A, Harrison S, Marsh DC, Schechter MT, Oviedo-Joekes E. Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with patients receiving injectable opioid agonist treatment. Substance Abuse Treatment, Prevention, and Policy. 16: 68. PMID 34530878 DOI: 10.1186/s13011-021-00399-2 |
0.031 |
|
2023 |
Oviedo-Joekes E, Dobischok S, Carvajal J, MacDonald S, McDermid C, Klakowicz P, Harrison S, LaJeunesse J, Chow N, Brown M, Gill S, Schechter M. Clients' experiences on North America's first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study. Bmc Health Services Research. 23: 553. PMID 37237256 DOI: 10.1186/s12913-023-09558-6 |
0.03 |
|
2023 |
Adams A, Blawatt S, MacDonald S, Finnick R, Lajeunesse J, Harrison S, Byres D, Schechter MT, Oviedo-Joekes E. Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review. The International Journal On Drug Policy. 117: 104058. PMID 37182352 DOI: 10.1016/j.drugpo.2023.104058 |
0.03 |
|
2016 |
Bonde MT, Pedersen M, Klausen MS, Jensen SI, Wulff T, Harrison S, Nielsen AT, Herrgård MJ, Sommer MO. Predictable tuning of protein expression in bacteria. Nature Methods. PMID 26752768 DOI: 10.1038/Nmeth.3727 |
0.03 |
|
2008 |
Johnstone-Robertson M, Clarke KG, Harrison ST. Characterization of the distribution of glucose oxidase in Penicillium sp. CBS 120262 and Aspergillus niger NRRL-3 cultures and its effect on integrated product recovery. Biotechnology and Bioengineering. 99: 910-8. PMID 17787009 DOI: 10.1002/bit.21642 |
0.029 |
|
2022 |
Dobischok S, Metcalfe RK, Matzinger EA, Lock K, Harrison S, MacDonald S, Amara S, Schechter MT, Bansback N, Oviedo-Joekes E. Feasibility of Testing Client Preferences for Accessing Injectable Opioid Agonist Treatment (iOAT): A Pilot Study. Patient Preference and Adherence. 16: 3405-3413. PMID 36582266 DOI: 10.2147/PPA.S391532 |
0.028 |
|
2024 |
Beaumont S, Magel T, MacDonald S, Harrison S, Schechter M, Oviedo-Joekes E. Shared decision-making and client-reported dose satisfaction in a longitudinal cohort receiving injectable opioid agonist treatment (iOAT). Substance Abuse Treatment, Prevention, and Policy. 19: 1. PMID 38172882 DOI: 10.1186/s13011-023-00585-4 |
0.028 |
|
2019 |
Oviedo-Joekes E, Palis H, Guh D, Marchand K, Brissette S, Harrison S, MacDonald S, Lock K, Anis AH, Marsh DC, Schechter MT. Treatment with injectable hydromorphone: Comparing retention in double blind and open label treatment periods. Journal of Substance Abuse Treatment. 101: 50-54. PMID 31174713 DOI: 10.1016/j.jsat.2019.03.012 |
0.027 |
|
2009 |
Oyekola OO, van Hille RP, Harrison ST. Study of anaerobic lactate metabolism under biosulfidogenic conditions. Water Research. 43: 3345-54. PMID 19559456 DOI: 10.1016/j.watres.2008.11.044 |
0.027 |
|
2018 |
Marchand K, Beaumont S, Westfall J, MacDonald S, Harrison S, Marsh DC, Schechter MT, Oviedo-Joekes E. Patient-centred care for addiction treatment: a scoping review protocol. Bmj Open. 8: e024588. PMID 30593556 DOI: 10.1136/bmjopen-2018-024588 |
0.027 |
|
2019 |
Oviedo-Joekes E, Palis H, Guh D, Marsh DC, MacDonald S, Harrison S, Brissette S, Anis AH, Schechter MT. Adverse Events During Treatment Induction With Injectable Diacetylmorphine and Hydromorphone for Opioid Use Disorder. Journal of Addiction Medicine. PMID 30747750 DOI: 10.1097/ADM.0000000000000505 |
0.027 |
|
2015 |
Ti L, Buxton J, Harrison S, Dobrer S, Montaner J, Wood E, Kerr T. Willingness to access an in-hospital supervised injection facility among hospitalized people who use illicit drugs. Journal of Hospital Medicine. 10: 301-6. PMID 25754871 DOI: 10.1002/jhm.2344 |
0.027 |
|
2023 |
Blawatt S, Harrison S, Byres D, Foreman J, Amara S, Burdge W, MacDonald S, Schechter M, Oviedo-Joekes E. The mobilization of nurse-client therapeutic relationships in injectable opioid agonist treatment: Autonomy, advocacy and action. Journal of Substance Use and Addiction Treatment. 209154. PMID 37652211 DOI: 10.1016/j.josat.2023.209154 |
0.026 |
|
2018 |
Palis H, Marchand K, Karamouzian M, MacDonald S, Harrison S, Guh D, Lock K, Brissette S, Anis AH, Krausz M, Marsh DC, Schechter MT, Oviedo-Joekes E. The association between nicotine dependence and physical health among people receiving injectable diacetylmorphine or hydromorphone for the treatment of chronic opioid use disorder. Addictive Behaviors Reports. 7: 82-89. PMID 29892701 DOI: 10.1016/j.abrep.2018.03.005 |
0.026 |
|
2020 |
Braithwaite V, Ti L, Fairbairn N, Ahamad K, McLean M, Harrison S, Wood E, Nolan S. Building a hospital-based addiction medicine consult service in Vancouver, Canada: the path taken and lessons learned. Addiction (Abingdon, England). PMID 33339073 DOI: 10.1111/add.15383 |
0.026 |
|
1991 |
Harrison ST, Chase HA, Dennis JS. The disruption of Alcaligenes eutrophus by high pressure homogenisation: key factors involved in the process. Bioseparation. 2: 155-66. PMID 1368082 |
0.025 |
|
2006 |
Balasundaram B, Harrison ST. Study of physical and biological factors involved in the disruption of E. coli by hydrodynamic cavitation. Biotechnology Progress. 22: 907-13. PMID 16739979 DOI: 10.1021/bp0502173 |
0.025 |
|
2008 |
Harrison S, Lydon J. Health visiting and community matrons: progress in partnership. Community Practitioner : the Journal of the Community Practitioners' & Health Visitors' Association. 81: 20-2. PMID 18335867 |
0.024 |
|
2013 |
Fagan MA, Ngoma IE, Chiume RA, Minnaar S, Sederman AJ, Johns ML, Harrison ST. The impact of drip irrigation on heap hydrology and microbial colonies in bioleaching Advanced Materials Research. 825: 455-458. DOI: 10.4028/www.scientific.net/AMR.825.455 |
0.023 |
|
2006 |
Harrison S, Berry L. Valuing people: health visiting and people with learning disabilities. Community Practitioner : the Journal of the Community Practitioners' & Health Visitors' Association. 79: 56-9. PMID 16493981 |
0.023 |
|
2017 |
Oviedo-Joekes E, Brissette S, MacDonald S, Guh D, Marchand K, Jutha S, Harrison S, Janmohamed A, Zhang DZ, Anis AH, Krausz M, Marsh DC, Schechter MT. Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorder. Drug and Alcohol Dependence. 176: 55-62. PMID 28521199 DOI: 10.1016/j.drugalcdep.2017.02.021 |
0.023 |
|
2013 |
Africa CJ, van Hille RP, Harrison ST. Attachment of Acidithiobacillus ferrooxidans and Leptospirillum ferriphilum cultured under varying conditions to pyrite, chalcopyrite, low-grade ore and quartz in a packed column reactor. Applied Microbiology and Biotechnology. 97: 1317-24. PMID 22410741 DOI: 10.1007/s00253-012-3939-x |
0.022 |
|
2020 |
Palis H, Harrison S, MACDonald S, Marsh DC, Schechter MT, Oviedo-Joekes E. Self-managing illicit stimulant use: A qualitative study with patients receiving injectable opioid agonist treatment. Drug and Alcohol Review. PMID 32588514 DOI: 10.1111/dar.13117 |
0.022 |
|
2022 |
Dogherty E, Patterson C, Gagnon M, Harrison S, Chase J, Boerstler J, Gibson J, Gill S, Nolan S, Ryan A. Implementation of a nurse-led overdose prevention site in a hospital setting: lessons learned from St. Paul's Hospital, Vancouver, Canada. Harm Reduction Journal. 19: 13. PMID 35120536 DOI: 10.1186/s12954-022-00596-7 |
0.021 |
|
2020 |
Palis H, Marchand K, Beaumont S, Guh D, Harrison S, MacDonald S, Brissette S, Marsh DC, Schechter MT, Oviedo-Joekes E. Physician Communication in Injectable Opioid Agonist Treatment: Collecting Patient Ratings With the Communication Assessment Tool. Journal of Addiction Medicine. PMID 32032213 DOI: 10.1097/ADM.0000000000000631 |
0.021 |
|
2014 |
Griffiths MJ, van Hille RP, Harrison ST. The effect of nitrogen limitation on lipid productivity and cell composition in Chlorella vulgaris. Applied Microbiology and Biotechnology. 98: 2345-56. PMID 24413971 DOI: 10.1007/s00253-013-5442-4 |
0.02 |
|
2022 |
Nolan S, Kelian S, Kerr T, Young S, Malmgren I, Ghafari C, Harrison S, Wood E, Lysyshyn M, Holliday E. Harm reduction in the hospital: An overdose prevention site (OPS) at a Canadian hospital. Drug and Alcohol Dependence. 239: 109608. PMID 36063622 DOI: 10.1016/j.drugalcdep.2022.109608 |
0.02 |
|
1991 |
Harrison ST. Bacterial cell disruption: a key unit operation in the recovery of intracellular products. Biotechnology Advances. 9: 217-40. PMID 14548738 |
0.02 |
|
2007 |
Silva-Stenico ME, Vengadajellum CJ, Janjua HA, Harrison ST, Burton SG, Cowan DA. Degradation of low rank coal by Trichoderma atroviride ES11. Journal of Industrial Microbiology & Biotechnology. 34: 625-31. PMID 17605059 DOI: 10.1007/s10295-007-0223-7 |
0.019 |
|
2020 |
Gustafson R, Demlow SE, Nathoo A, McKee G, MacDonald LE, Chu T, Sandhu J, Grafstein E, Hull M, Chittock D, Carere R, Krajden M, Sherlock CH, Harrison S, Buchner CS, et al. Routine HIV testing in acute care hospitals: Changing practice to curb a local HIV epidemic in Vancouver, BC. Preventive Medicine. 106132. PMID 32442444 DOI: 10.1016/j.ypmed.2020.106132 |
0.017 |
|
2014 |
Lynch M, Bost D, Wilson S, Maruki T, Harrison S. Population-genetic inference from pooled-sequencing data. Genome Biology and Evolution. 6: 1210-8. PMID 24787620 DOI: 10.1093/Gbe/Evu085 |
0.017 |
|
2011 |
Griffiths MJ, Garcin C, van Hille RP, Harrison ST. Interference by pigment in the estimation of microalgal biomass concentration by optical density. Journal of Microbiological Methods. 85: 119-23. PMID 21329736 DOI: 10.1016/j.mimet.2011.02.005 |
0.017 |
|
2020 |
Palis H, Guh D, MacDonald S, Harrison S, Brissette S, Marsh DC, Schechter MT, Oviedo-Joekes E. Longitudinal patterns of cocaine use among patients receiving injectable hydromorphone or diacetylmorphine for the treatment of opioid use disorder: A growth curve modeling approach. Drug and Alcohol Dependence. 108333. PMID 33268225 DOI: 10.1016/j.drugalcdep.2020.108333 |
0.015 |
|
2015 |
Harrison ST, Driessen PF. Time-compression overlap add: Description and implementation Ieee Pacific Rim Conference On Communications, Computers, and Signal Processing - Proceedings. 2015: 64-69. DOI: 10.1109/PACRIM.2015.7334810 |
0.015 |
|
1998 |
Casadei MA, Esteves de Matos R, Harrison ST, Gaze JE. Heat resistance of Listeria monocytogenes in dairy products as affected by the growth medium. Journal of Applied Microbiology. 84: 234-9. PMID 9633638 |
0.015 |
|
2008 |
Balasundaram B, Harrison ST. Influence of the extent of disruption of Bakers' yeast on protein adsorption in expanded beds. Journal of Biotechnology. 133: 360-9. PMID 17933410 DOI: 10.1016/j.jbiotec.2007.07.724 |
0.015 |
|
2019 |
Sharma NR, Gopakumar H, Harrison S, Ehmke N, Zelt C. Gastric Gastrointestinal Stromal Tumors (GIST): a Case Series and Current State of the Art in the Workup and Treatment of This Rare Disease. Journal of Gastrointestinal Cancer. 50: 548-555. PMID 29192406 DOI: 10.1007/s12029-017-0034-7 |
0.015 |
|
2006 |
Clarke KG, Johnstone-Robertson M, Price B, Harrison ST. Location of glucose oxidase during production by Aspergillus niger. Applied Microbiology and Biotechnology. 70: 72-7. PMID 16133329 DOI: 10.1007/s00253-005-0031-9 |
0.014 |
|
2000 |
Nemati M, Lowenadler J, Harrison ST. Particle size effects in bioleaching of pyrite by acidophilic thermophile Sulfolobus metallicus (BC). Applied Microbiology and Biotechnology. 53: 173-9. PMID 10709979 |
0.014 |
|
2013 |
Jones GC, van Hille RP, Harrison ST. Reactive oxygen species generated in the presence of fine pyrite particles and its implication in thermophilic mineral bioleaching. Applied Microbiology and Biotechnology. 97: 2735-42. PMID 22584431 DOI: 10.1007/s00253-012-4116-y |
0.014 |
|
2021 |
Rudzinski K, Xavier J, Guta A, Chan Carusone S, King K, Phillips JC, Switzer S, O'Leary B, Baltzer Turje R, Harrison S, de Prinse K, Simons J, Strike C. Feasibility, acceptability, concerns, and challenges of implementing supervised injection services at a specialty HIV hospital in Toronto, Canada: perspectives of people living with HIV. Bmc Public Health. 21: 1482. PMID 34325681 DOI: 10.1186/s12889-021-11507-z |
0.013 |
|
2016 |
Oviedo-Joekes E, Guh D, Brissette S, Marchand K, MacDonald S, Lock K, Harrison S, Janmohamed A, Anis AH, Krausz M, Marsh DC, Schechter MT. Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence: A Randomized Clinical Trial. Jama Psychiatry. PMID 27049826 DOI: 10.1001/jamapsychiatry.2016.0109 |
0.013 |
|
2017 |
Palis H, Marchand K, Guh D, Brissette S, Lock K, MacDonald S, Harrison S, Anis AH, Krausz M, Marsh DC, Schechter MT, Oviedo-Joekes E. Men's and women's response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder. Substance Abuse Treatment, Prevention, and Policy. 12: 25. PMID 28526048 DOI: 10.1186/s13011-017-0110-9 |
0.013 |
|
2020 |
Kriegsman B, Harrison S, Sobin L. Women and Minorities in Otolaryngology: A Historical Perspective and Analysis of Current Representation. Otolaryngologic Clinics of North America. PMID 33153735 DOI: 10.1016/j.otc.2020.09.017 |
0.012 |
|
2005 |
Harrison S, Berry L. Improving primary care services for people with learning disability. Nursing Times. 101: 38-40. PMID 15658237 |
0.012 |
|
2004 |
Gluodenis T, Harrison S. Homeland security and bioterrorism applications: detection of bioweapon pathogens by microfluidic-based electrophoretic DNA analysis. Mlo: Medical Laboratory Observer. 36: 34-8. PMID 15002151 |
0.011 |
|
2017 |
Oviedo-Joekes E, Palis H, Guh D, Marchand K, Brissette S, Lock K, MacDonald S, Harrison S, Anis AH, Krausz M, Marsh DC, Schechter MT. Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependence. Drug and Alcohol Review. PMID 28593748 DOI: 10.1111/dar.12573 |
0.01 |
|
2023 |
Thompson J, O'Camb JW, Barrett RCA, Harrison S, Blair MR. Robustness of performance during domain change in an esport: A study of within-expertise transfer. Plos One. 18: e0295037. PMID 38060533 DOI: 10.1371/journal.pone.0295037 |
0.01 |
|
2018 |
Bansback N, Guh D, Oviedo-Joekes E, Brissette S, Harrison S, Janmohamed A, Krausz M, MacDonald S, Marsh DC, Schechter MT, Anis AH. Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial. Addiction (Abingdon, England). PMID 29589873 DOI: 10.1111/add.14171 |
0.01 |
|
2017 |
Marchand K, Palis H, Fikowski J, Harrison S, Spittal P, Schechter MT, Oviedo-Joekes E. The Role of Gender in Suicidal Ideation among Long-term Opioid Users. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743717711173. PMID 28521111 DOI: 10.1177/0706743717711173 |
0.01 |
|
2016 |
Palis H, Marchand K, Peng D, Fikowski J, Harrison S, Spittal P, Schechter MT, Oviedo-Joekes E. Factors Associated with Perceived Abuse in the Health Care System Among Long-Term Opioid Users: A Cross-Sectional Study. Substance Use & Misuse. 1-14. PMID 27096889 DOI: 10.3109/10826084.2016.1155605 |
0.01 |
|
2015 |
Marchand K, Palis H, Peng D, Fikowski J, Harrison S, Spittal P, Schechter MT, Oviedo-Joekes E. The Role of Gender in Factors Associated With Addiction Treatment Satisfaction Among Long-Term Opioid Users. Journal of Addiction Medicine. 9: 391-8. PMID 26335006 DOI: 10.1097/ADM.0000000000000145 |
0.01 |
|
2011 |
Murfield J, Cooke M, Moyle W, Shum D, Harrison S. Conducting randomized controlled trials with older people with dementia in long-term care: Challenges and lessons learnt. International Journal of Nursing Practice. 17: 52-9. PMID 21251154 DOI: 10.1111/j.1440-172X.2010.01906.x |
0.01 |
|
2010 |
Cooke M, Moyle W, Shum D, Harrison S, Murfield J. A randomized controlled trial exploring the effect of music on quality of life and depression in older people with dementia. Journal of Health Psychology. 15: 765-76. PMID 20603300 DOI: 10.1177/1359105310368188 |
0.01 |
|
2008 |
Zarabozo C, Harrison S. Payment policy and the growth of Medicare Advantage. Health Affairs (Project Hope). 28: w55-67. PMID 19029153 DOI: 10.1377/hlthaff.28.1.w55 |
0.01 |
|
2002 |
White RJ, Rudkin ST, Harrison ST, Day KL, Harvey IM. Pulmonary rehabilitation compared with brief advice given for severe chronic obstructive pulmonary disease. Journal of Cardiopulmonary Rehabilitation. 22: 338-44. PMID 12370595 |
0.01 |
|
2002 |
Schlosser RJ, Zachmann G, Harrison S, Gross CW. The endoscopic modified Lothrop: long-term follow-up on 44 patients. American Journal of Rhinology. 16: 103-8. PMID 12030355 |
0.01 |
|
Hide low-probability matches. |